Sharemaestro Newsreel

CareDx, Inc. SEC Filing (Aug 5, 2026)

This article details a CareDx, Inc. (CDNA) SEC Filing on Form 144, dated August 5, 2026. The filing indicates a proposed sale of 20,000 shares of common stock by an individual who acquired them as compensation for past services in 2015, with an aggregate …

Will Sotera Health's (SHC) Sharp Profit Rebound and Higher EPS Rewrite Its Turnaround Narrative?

Sotera Health (SHC) reported a significant profit rebound in Q2 2026, with net income rising to US$53.64 million and EPS to US$0.19, shifting from a net loss in the first half of the year. This turnaround in profitability is a key catalyst for its …

Sotera Health (NASDAQ:SHC) Beats Q2 Estimates and Raises Guidance, But Shares Slip

Sotera Health (SHC) exceeded analyst expectations for its second-quarter earnings and revenue, reporting $0.26 adjusted EPS and $321.4 million in net revenues. The company also raised its full-year guidance for net revenues and adjusted EPS, and improved its net leverage to 3.0 times. Despite …

Qiagen N.V. 2026 Q2 - Results - Earnings Call Presentation (NYSE:QGEN) 2026-08-06

Check-Cap: MBody AI Takes Autonomous Services Outdoors, Expanding Addressable Market

Check-Cap (NASDAQ: MBAI) announced that MBody AI, with which it plans to merge, has expanded its addressable market by securing exclusive U.S. distribution rights for outdoor cleaning robots in gaming and hospitality across six states. This move allows MBody AI to automate services outdoors …

Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimates

Sotera Health Company (SHC) reported strong Q2 2026 earnings, beating analyst estimates for both EPS ($0.26 vs. $0.24) and revenue ($321.38 million vs. $310.27 million). This marks the fourth consecutive quarter the company has surpassed both earnings and revenue expectations. Despite this positive performance, …

Sotera Health Company (NASDAQ:SHC) Surprises With Strong Q2 CY2026

Sotera Health (NASDAQ:SHC) reported strong Q2 CY2026 results, exceeding revenue and adjusted EPS expectations with sales up 9.2% year-on-year to $321.4 million. The company slightly increased its full-year revenue and Adjusted EPS guidance, demonstrating focused execution across its business units. Despite a mediocre 6.7% …

Dimensional Fund Advisors LP Sells 104,038 Shares of Castle Biosciences, Inc. $CSTL

Dimensional Fund Advisors LP reduced its stake in Castle Biosciences (NASDAQ:CSTL) by 9.1%, selling 104,038 shares but still retaining over 1 million shares valued at approximately $25.5 million. This comes as Castle Biosciences exceeded Q1 revenue and EPS expectations, reporting $99.86 million in revenue …

Labcorp EVP Amy Summy sells $283k in common stock

Labcorp Executive Vice President Amy Summy sold 924 shares of company common stock for $283,427 on August 4, 2026, at a price of $306.74 per share. Following this transaction, she directly holds 6,955.50 shares. This news follows Labcorp's strong second-quarter results, where adjusted EPS …

IQVIA Holdings Inc (IQV) surges as weekly volume screen lights up

The healthcare research-services stock closed at 235.02 USD after a broad rebound across one-, four- and twelve-week measures.

QIAGEN NV : Deutsche Bank maintains a Buy rating

Deutsche Bank has reiterated its Buy rating for QIAGEN NV, with analyst Jan Koch maintaining a positive outlook on the stock. This comes amidst recent news that Jefferies also reiterated a Buy rating for QIAGEN and that the company's Q2 earnings were ahead of …

Earnings Flash (SHC) Sotera Health Company Reports Q2 Revenue $321.4M, vs. FactSet Est of $309.7M

Sotera Health Company (SHC) announced its Q2 revenue of $321.4 million, surpassing FactSet's estimate of $309.7 million. The company also reported Q2 adjusted EPS of $0.26 per share, exceeding the FactSet estimate of $0.24 per share. Following these results, Sotera Health has lifted the …

Sotera Health (SHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Sotera Health (SHC) reported strong Q2 2026 earnings, with revenue up 9.2% year-over-year to $321.38 million and EPS at $0.26. The company surpassed Zacks Consensus Estimates for both revenue and EPS, showing a surprise of +3.29% and +8.33% respectively. Key segment metrics for Sterigenics, …

Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group, and More

This article details Thursday's top Wall Street analyst research calls, including upgrades, downgrades, and new initiations for various companies like Charles River Laboratories, Global Payments, AppLovin, and HubSpot. It also provides a snapshot of the market on Wednesday, noting mixed futures, a strong Dow …

Waters Corp Raised to Buy From Hold by TD Cowen

TD Cowen has upgraded Waters Corp from a "Hold" rating to a "Buy" rating. This indicates a more positive outlook on the company's stock performance from the financial institution.

GeneDx Holdings Corp. (NASDAQ:WGS) Analysts Are Pretty Bullish On The Stock After Recent Results

Analysts are showing increased optimism for GeneDx Holdings Corp. (NASDAQ:WGS) after its latest second-quarter results, which saw revenues beat expectations and statutory losses narrow more than anticipated. Although revenue forecasts remain unchanged for the coming year, analysts have revised their loss per share predictions, …

Biodesix, Inc. Reports Impairment Loss on Intangible Assets for the Second Quarter Ended June 30, 2026

Biodesix, Inc. announced an impairment loss on intangible assets for the second quarter ended June 30, 2026. The reported impairment loss was $12,000, a decrease from $26,000 in the same period last year. This information was released on August 5, 2026, as part of …

Sotera Health Reports Strong Q2 2026 Results, Raises Full-Year Outlook

Is MEDP Worth Buying as Growth Collides With a Premium Valuation?

Medpace Holdings, Inc. (MEDP) exhibits compelling growth with double-digit earnings, strong profitability, and improving bookings, along with a significant pipeline for 2027. However, its valuation is considerably higher than industry and market averages. While the company's operational quality is high, the premium valuation and …

ICON Announces Pricing of USD 2.15 Billion Notes

ICON plc announced the pricing of $2.15 billion in senior unsecured notes through its subsidiary, ICON Investments Six Designated Activity Company. The offering, expected to close on August 13, 2026, will comprise notes due in 2029, 2031, and 2036. Proceeds are intended to repay …

Clinical Visits Keep Falling. IDEXX Laboratories’ Q2 Earnings Report Say That Doesn’t Matter.

IDEXX Laboratories reported strong Q2 2026 earnings, beating revenue and EPS estimates, despite a decline in U.S. same-store clinical veterinary visits. The company raised its full-year guidance, driven by robust performance in its CAG Diagnostics segment and the successful rollout of its inVue Dx …

Personalis Inc (PSNL) News, Articles, Events & Latest Updates

This article compiles recent news and updates for Personalis Inc (PSNL), primarily focusing on its Q2 2026 financial results, which reported a loss but topped revenue estimates, and the significant acquisition by Tempus AI for $1.5 billion. Several reports also highlight ongoing legal inquiries …

Janus Henderson Group PLC Sells 166,218 Shares of Icon Plc $ICLR

Janus Henderson Group PLC significantly reduced its stake in Icon Plc (NASDAQ:ICLR) by 66.9% in the first quarter, selling 166,218 shares and retaining 82,061 shares valued at approximately $9.1 million. Despite this reduction, institutional investors collectively own 95.61% of Icon's stock. Icon recently reported …

Castle Biosciences (NASDAQ:CSTL) COO Sells 8,586 Shares of Stock

Form 4 BillionToOne Inc For: 6 August By Investing.com

This article reports a Form 4 filing for BillionToOne Inc. on August 6th. Form 4 filings are legally required documents by the U.S. Securities and Exchange Commission that must be filed by company insiders when they buy or sell shares in their own company. …

Natera president Solomon Moshkevich sells $905,626 in stock

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 3,410 shares of company stock worth $905,626 on August 3, 2026, with prices ranging from $259.98 to $268.6964 per share. These sales included shares to cover tax obligations from vested RSUs and shares sold …

Natera president John Fesko sells $79,056 in company stock.

Natera's President and Chief Business Officer, John Fesko, sold 295 shares of the company's stock worth $79,056 to cover tax obligations related to vested restricted stock units. The sale occurred while Natera's stock is near its 52-week high and has shown a 99% return …

Form 4 Natera Inc For: 6 August By Investing.com

This article reports on a Form 4 filing for Natera Inc. on August 6th. It mentions the company's stock symbol NTRA, which experienced a -3.65% change, and invites readers to view comments. The content is very brief and mostly consists of navigation and market …

5 Insightful Analyst Questions From Mettler-Toledo’s Q2 Earnings Call

Quidelortho Corp (QDEL) News, Articles, Events & Latest Updates

This article provides recent news and updates for QuidelOrtho Corp (QDEL), highlighting its strong Q2 2026 earnings and revenue performance, which surpassed analyst estimates. It also includes details about the company's financial results, upcoming earnings reports, and an article discussing the changing landscape of …

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 2026: Revenue $1B, EPS ($0.03) — 10-Q Summary

Charles River Laboratories International, Inc. reported Q3 2026 results, with revenue of $1 billion and a diluted EPS loss of ($0.03), reflecting a 2.7% year-over-year decline in revenue and a significant drop in net income. The company is implementing cost-saving measures and restructuring actions …

Arrowstreet Capital Limited Partnership Sells 328,169 Shares of Revvity Inc. $RVTY

Natera (NASDAQ: NTRA) lifts 2026 outlook on $753M Q2 revenue

Countdown to RadNet (RDNT) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Check-Cap (NASDAQ: MBAI) targets Q3 2026 close for MBody AI merger

Insight Molecular Diagnostics Ord Shs (IMDX) Earnings Forecast: Future EPS & Revenue Growth Estimates